← Open Payments lookup

STEPHANIE KOCHUPARAMBIL: Open Payments

NPI 1093330722 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,317 in 118 payments from 19 companies in 2025. Trend: 2023 $1,336 · 2024 $1,426 · 2025 $2,317

Food & beverage: $2,317
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.18$455
Otsuka America Pharmaceutical, Inc.10$190
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$190
Janssen Pharmaceuticals, Inc13$179
Takeda Pharmaceuticals U.S.A., Inc.11$168
ABBVIE INC.7$162
E.R. Squibb & Sons, L.L.C.9$153
Axsome Therapeutics, Inc.6$143
Lundbeck LLC9$138
Corium, LLC5$131

Products named: INGREZZA, REXULTI, CAPLYTA, SPRAVATO, TRINTELLIX, VRAYLAR, COBENFY, Azstarys.

Industry payments across TX — which companies pay providers there.